FDA approves first shock wave device made to heal wounds

After two double-blind studies, the results showed an increase in wound healing at 24 weeks with a 44 percent wound closure rate with the real Dermapace device, vs. a 30 percent closure rate for patients treated with a fake system. Now that this device has been approved, it also opens the door for similar technology, if it can show that it’s “substantially equivalent.”